1. Home
  2. PHAR vs CRESY Comparison

PHAR vs CRESY Comparison

Compare PHAR & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CRESY
  • Stock Information
  • Founded
  • PHAR 1988
  • CRESY 1936
  • Country
  • PHAR Netherlands
  • CRESY Argentina
  • Employees
  • PHAR N/A
  • CRESY N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CRESY Real Estate
  • Sector
  • PHAR Health Care
  • CRESY Finance
  • Exchange
  • PHAR Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • PHAR 508.8M
  • CRESY 539.7M
  • IPO Year
  • PHAR N/A
  • CRESY 1997
  • Fundamental
  • Price
  • PHAR $8.61
  • CRESY $9.06
  • Analyst Decision
  • PHAR Strong Buy
  • CRESY
  • Analyst Count
  • PHAR 1
  • CRESY 0
  • Target Price
  • PHAR $37.00
  • CRESY N/A
  • AVG Volume (30 Days)
  • PHAR 7.8K
  • CRESY 126.1K
  • Earning Date
  • PHAR 10-24-2024
  • CRESY 11-07-2024
  • Dividend Yield
  • PHAR N/A
  • CRESY 8.30%
  • EPS Growth
  • PHAR N/A
  • CRESY N/A
  • EPS
  • PHAR N/A
  • CRESY 0.13
  • Revenue
  • PHAR $277,557,000.00
  • CRESY $780,016,938.00
  • Revenue This Year
  • PHAR $21.91
  • CRESY N/A
  • Revenue Next Year
  • PHAR $9.33
  • CRESY N/A
  • P/E Ratio
  • PHAR N/A
  • CRESY $6.99
  • Revenue Growth
  • PHAR 34.54
  • CRESY 0.56
  • 52 Week Low
  • PHAR $6.65
  • CRESY $6.56
  • 52 Week High
  • PHAR $13.20
  • CRESY $10.75
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.47
  • CRESY 51.90
  • Support Level
  • PHAR $8.22
  • CRESY $8.84
  • Resistance Level
  • PHAR $9.09
  • CRESY $9.66
  • Average True Range (ATR)
  • PHAR 0.43
  • CRESY 0.40
  • MACD
  • PHAR 0.02
  • CRESY -0.03
  • Stochastic Oscillator
  • PHAR 66.08
  • CRESY 45.45

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: